CVAC Stock Price | CureVac N.V. Stock Quote (U.S.: Nasdaq)
CVAC | Complete CureVac N.V. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Stay updated with breaking news from Ingmar Hoerr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CVAC | Complete CureVac N.V. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Robert Malone has become a favorite source of information for people who aren't sure about the safety of mRNA vaccines.
FRANKFURT, Oct 12 — Germany’s CureVac said today it is no longer seeking European regulatory approval for its coronavirus vaccine, and will focus instead on a more promising second-generation jab. The decision comes after final trial results in July confirmed that CureVac’s first vaccine had...
Germany's CureVac said Tuesday it is no longer seeking European regulatory approval for its coronavirus vaccine, and will focus instead on a more promising seco
The decision comes after final trial results in July confirmed that CureVac's first vaccine had an efficacy rate of just 48%, well below that of faster rivals Pfizer-BioNTech and Moderna, whose vaccines are based on the same mRNA technology.